In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Congress 2012 Embargo Break

The embargo on the TRILOGY ACS (TRILOGY-ACS: Prasugrel versus clopidodrel for patients with Unstable Angina/NSTEMI who are medically managed without revascularization) trial was broken today by Medscape Medical News.

According to article 5 of the ESC Media Policy, breaking of the embargo by a reporter leads to:

5. Breaking of the embargo policy by a reporter leads to:
• Immediate suspension of the reporter’s media credentials
• Immediate barring of the reporter from the meeting premises
• Removal of the reporter’s name from the ESC Press distribution list for 1 year
• No access as a media representative to the following year’s ESC Congress
• No access as a media representative to any other congresses organized by the ESC for 1 year
• Media outlets that employ the reporter or who hired the freelancer to write for them will
be barred from accessing next year’s ESC Congress and from sending reporters to any other ESC organised congress for 1 year.

The ESC Press Office will enforce the media policy: Medscape Medical News reporters present at the ESC Congress 2012 have been asked to hand in their badges and leave the premises. All of the above will also be applied.

European Society of Cardiology